Detection of Circulating Tumor DNA Through Liquid Biopsies in Ovarian Cancer Patients and Evaluation of Prognostic and Predictive Values of Circulating Tumor DNA Assay.
CompletedOBSERVATIONAL
Enrollment
300
Participants
Timeline
Start Date
September 10, 2019
Primary Completion Date
June 30, 2022
Study Completion Date
June 30, 2022
Conditions
Ovarian Cancer
Trial Locations (1)
Unknown
Yonsei University Health System, Severance Hospital, Seoul
All Listed Sponsors
lead
Yonsei University
OTHER
NCT05504174 - Detection of Circulating Tumor DNA Through Liquid Biopsies in Ovarian Cancer Patients and Evaluation of Prognostic and Predictive Values of Circulating Tumor DNA Assay. | Biotech Hunter | Biotech Hunter